Loading company…
Vytala develops food-based solutions for gastrointestinal health and nutrient absorption.
Vytala develops solutions for gastrointestinal health, with a focus on fat malabsorption. Its Lym-X-Sorb® lipid technology is designed to improve absorption of dietary fats and nutrients for people with conditions such as cystic fibrosis and pancreatic insufficiency. Founded in 2023 by CEO Jim O’Connell, it is based in Exton, Pennsylvania, and is at seed stage. In September 2024, it raised pre-seed funding led by Robin Hood Ventures, with participation from Ulu Ventures, Jumpstart New Jersey Angel Network, Delaware Crossing Investor Group and The MBA Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in